Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 18Testicular Neoplasms 13Testicular Germ Cell Tumor 9Sarcoma 9Teratoma 6Central Nervous System Neoplasms 6Neuroectodermal Tumors, Primitive, Peripheral 5Endodermal Sinus Tumor 5Seminoma 4Ovarian Germ Cell Cancer 4Osteosarcoma 4Liposarcoma 4Kidney Neoplasms 4Hemangiosarcoma 4Fibrosarcoma 4Carcinoma, Embryonal 4Wilms Tumor 3Sarcoma, Synovial 3Sarcoma, Endometrial Stromal 3Neurofibrosarcoma 3Malignant mesenchymal tumor 3Leiomyosarcoma 3Histiocytoma, Malignant Fibrous 3Hemangiopericytoma, Malignant 3Desmoplastic Small Round Cell Tumor 3Carcinoma, Ovarian Epithelial 3Uterine Cervical Neoplasms 2Pheochromocytoma 2Optic Nerve Glioma 2Neuroblastoma 2

Interventions

belinostat 2Radiotherapy 1Paclitaxel 1Ifosfamide 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mixed Tumor, Mesodermal × Ifosfamide × Gynecologic × Clear all
NCT00231842 2019-01-23

Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the Uterus

Montefiore Medical Center

Phase 2 Completed
30 enrolled 9 charts
Gynecologic

Uterine Neoplasms, Mixed Tumor, Mesodermal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡